Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to ...

The article 🌱 Patch AM: How a new state jobs bill could boost Gaithersburg’s biotech future appeared first on Gaithersburg ...

Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy ...

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...

Driving Innovation Across Emerging Markets and Transformative Technologies ...

Immix Biopharma Inc (NASDAQ: IMMX) shares are trading lower Monday after the company filed a new shelf registration statement ...

The annual list spotlights the innovations poised to make the greatest impact on our world and shape the future of technology.

The biopharmaceutical sector finally regained its footing in 2025. Here are 5 issues that could determine whether the renewed ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Biopharmaceutical company Zonsen PepLib Biotech said in a company statement on Monday that it has struck a global licensing deal with Swiss multinational pharmaceutical company Novartis to develop a ...